Brief: Takara Bio signs exclusive license agreement of Oncolytic virus HF10 with Otsuka Pharmaceutical

Takara Bio

15/12/2016 06:26

Dec 15 (Reuters) - Takara Bio  4974.T : 
     
    * Says it signed an exclusive license agreement of Oncolytic 
virus HF10 with Otsuka Pharmaceutical  
    * Says it gives development and sale right of HF10 to Otsuka 
Pharmaceutical 
     
     
    Source text in Japanese: https://goo.gl/l0GBXC 
    Further company coverage: 4974.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010 
62674724;)(Reuters 
Messaging:)(shuai.liu.reuters.com@reuters.net))